Увійти

Готові списки джерел за темами / Legionnaires' disease

Добірка наукової літератури з теми "Legionnaires' disease"

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 28 лютого 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Legionnaires' disease".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

За допомогою хмари тегів ви можете побачити ще більше пов’язаних тем досліджень, а відповідні кнопки після кожного розділу сторінки дозволяють переглянути розширені списки книг, статей тощо на обрану тему.

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій
Звіти організацій

Статті в журналах з теми "Legionnaires' disease":

1

Saks, Mark. "Legionnairesʼ Disease Not Just For Legionnaires Anymore". Emergency Medicine News 28, № 1 (січень 2006): 6–8. http://dx.doi.org/10.1097/00132981-200601000-00016.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Gould, Dinah. "Legionnaires’ disease." Nursing Standard 17, no. 45 (July 23, 2003): 41–44. http://dx.doi.org/10.7748/ns2003.07.17.45.41.c3423.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Gould, Dinah. "Legionnaires’ disease." Nursing Standard 17, no. 45 (July 23, 2003): 41–44. http://dx.doi.org/10.7748/ns.17.45.41.s55.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Prozorovsky, S. V., V. I. Pokrovsky, and I. S. Tartakovsky. "Legionnaires' disease." Kazan medical journal 66, no. 6 (December 15, 1985): 464. http://dx.doi.org/10.17816/kazmj62258.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Davis, Gerald S., and Washington C. Winn. "Legionnaires' Disease:." Clinics in Chest Medicine 8, no. 3 (September 1987): 419–39. http://dx.doi.org/10.1016/s0272-5231(21)01038-8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Sandeep, K. R., and B. S. Sandhya Rani. "Legionnaires ’Disease." International Journal of Nursing Education and Research 6, no. 4 (2018): 439. http://dx.doi.org/10.5958/2454-2660.2018.00106.0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Fallon, R. J. "Legionnaires' Disease." Scottish Medical Journal 39, no. 5 (October 1994): 135–37. http://dx.doi.org/10.1177/003693309403900502.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

BUSSEN, SELENA V. "Legionnaires' Disease." Radiology 194, no. 2 (February 1995): 406. http://dx.doi.org/10.1148/radiology.194.2.406.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

PORTER, RICHARD T. "Legionnaires' Disease." Radiology 195, no. 3 (June 1995): 638. http://dx.doi.org/10.1148/radiology.195.3.638.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Brundrett, Geoffrey. "Legionnaires’ disease." Journal of the Royal Society for the Promotion of Health 122, no. 3 (September 2002): 146–47. http://dx.doi.org/10.1177/146642400212200308.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Legionnaires' disease":

1

De, Goveia C. "Legionella infections : a review of the literature and a prospective serological study of the incidence of Legionnaires disease at Groote Schuur Hospital." Master's thesis, University of Cape Town, 1989. http://hdl.handle.net/11427/25585.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

A prospective study of patients with pneumonia admitted to Groote Schuur Hospital took place over a one-year period in an attempt to assess the incidence of legionella pneumonia. Acute and convalescent serum samples were obtained from 113 patients. Eight patients (7,1%) showed a fourfold rise in antibody titre against Legionella pneumophila group 1 antigen by indirect immunofluorescent test (IFAT). The findings suggest that legionella pneumonia, although not common, should be considered in the aetiology of pneumonia at Groote Schuur Hospital. The results are presented and a review of the literature is undertaken.

2

IJzerman, E. P. F. "Progress in diagnostics and prevention of Legionnaires' disease." [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2009. http://irs.ub.rug.nl/ppn/315954442.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Doyle, Robyn Michelle. "Molecular analysis of Legionella longbeachae serogroup 1 virulence." Title page, contents and summary only, 2000. http://web4.library.adelaide.edu.au/theses/09PH/09phd7546.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Bibliography: leaves 246-304. Describes experiments aimed at characterising the potential virilant factors of Legionella longbeachae sg 1, an important human pathogen which is responsible for nearly half of all clinical cases of Legionella related pneumonia reported each year.

4

Sakamoto, Ryota. "Is driving a car a risk for Legionnaires' disease?" Kyoto University, 2009. http://hdl.handle.net/2433/126450.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Bhopal, Rajinder Singh. "Geographic variation in the incidence of Legionnaires' disease in Scotland." Thesis, University of Edinburgh, 1991. http://hdl.handle.net/1842/26329.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

The major sources of infection for Legionnaire's Disease, identified by study of outbreaks, are hot water systems and cooling towers. However, most cases are not part of outbreaks and, for these, the source of infection is rarely traced. The principal aim of this study was to help understand the source of non-outbreak infection by examining the epidemiology of the disease in Scotland. Of the recognized cases which met the study case-definition, 366 were ill between 1978 to 1986 giving a mean annual incidence rate of 7.9 per million. The annual incidence varied in Scotland (range 3.1 to 20.2) and within health boards. Geographical variations were demonstrated by health board, by city and within cities, particularly for non-travel infection. For example, the cumulative incidence rate per million for non-travel, non-outbreak disease in Greater Glasgow Health Board (GGHB) was 130 compared to 45 for the whole of Scotland, and 11, 33 and 50 in Tayside, Lanarkshire and Lothian Health Boards respectively. Of 16 postcode sectors with a high incidence of disease in Scotland, 14 were in GGHB. In GGHB, the residence of non-travel, non-outbreakcases (but not of travel-related ones) was clustered in central areas. Previously unrecognised clustering was also found in other health boards. These variations were not fully explained by differences in the population's exposure to diagnostic tests, as indicated by the number of serology tests requested by Scottish hospitals; the diagnostic service and approach of bacteriology laboratories; and the approach of hospital consultants to the diagnosis of Legionnaires' Disease. Differences in host susceptibility, as reflected by socio-economic status and the incidence of other respiratory disease, were small and did not explain the variation. In the City of Glasgow, many cooling towers were not maintained in accord with recommendations and posed a theoretical risk of infection. The location of residence of non-travel cases was associated with the location of premises with cooling towers, the incidence of non-travel Legionnaires' Disease being more than three times higher in areas of Glasgow within 0.5 kilometres of a cooling tower than in areas more than one kilometre away. The best explanation for these observations is that cooling towers were a major source of non-travel, non-outbreak infection. Hence, for the investigation and prevention of such infection, the emphasis should be on cooling tower maintenance. Close surveillance of apparently sporadic disease is recommended as the basis for disease control and future research.

6

Fry, Norman Kenneth. "Analysis of the ribosomal RNA genes of the family Legionellaceae for classification and identification." Thesis, London School of Hygiene and Tropical Medicine (University of London), 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.315280.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Boswell, Timothy Charles John. "The serological crossreaction between legionella and campylobacter." Thesis, King's College London (University of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.267616.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Wilmot, Peter Nicholas. "Modelling cooling tower risk for Legionnaires' Disease using Bayesian Networks and Geographic Information Systems." Title page, contents and conclusion only, 1999. http://web4.library.adelaide.edu.au/theses/09SIS.M/09sismw744.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Includes bibliographical references (leaves 115-120) Establishes a Bayesian Belief Network (BBN) to model uncertainty of aerosols released from cooling towers and Geographic Information Systems (GIS) to create a wind dispersal model and identify potential cooling towers as the source of infection. Demonstrates the use of GIS and BBN in environmental epidemiology and the power of spatial information in the area of health.

9

James, Brian William. "Nutrient availability modulating physiology and pathogenicity of Legionella pneumophila." Thesis, Open University, 1997. http://oro.open.ac.uk/57693/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

A virulent strain of Legionella pneumophila serogroup 1 was established in continuous culture under defined iron-replete conditions at pH 6.9. Iron-limitation and extremes of pH (6.0 and 7.8) influenced the growth and metabolism of L. pneumophila, as manifested by increased metabolic activity, impaired energy coupling, and altered metabolic fluxes. In particular, the physiological versatility of L. pneumophila was demonstrated by a significant decrease in the iron content of biomass (6-fold increase in Yiron), coupled with reduced metabolic efficiency (Y, on), in response to iron-limited growth. Iron limitation promoted the accumulation of significant intracellular reserves of poly- ß-hydroxybutyrate (16 % cell dry wt.), which supported long-term survival of L. pneumophila under starvation conditions. Expression of the important pathogenicity factor, the zinc metalloprotease, was regulated by iron availability. Common iron acquisition mechanisms, such as siderophores and transferrin receptors, were not elaborated by iron-limited cells. However, human transferrin was identified as a potential iron source for L. pneumophila, with the zinc metalloprotease mediating transferrin digestion and possibly iron acquisition. Iron-limitation and extremes of pH also influenced cellular morphology and the surface properties of L. pneumophila, promoting the formation of uniform cultures of short rod-shaped bacteria, with altered fatty acid, phospholipid and protein composition. In addition to morphological and physiological adaptation, iron limitation had a significant effect on the virulence of L. pneumophila. Iron-replete cells grown at pH 6.9 and 6.0 were highly virulent in a guinea pig model. However, the virulence of L. pneumophila was significantly attenuated (P < 0.05) in response to iron-limited growth. This phenomenon was reversible, and correlated with reduced phagocytosis and / or reduced intracellular survival following infection. Decreasing the pH of iron-limited cultures to 6.0 did not stimulate recovery of culture virulence. Therefore, this study clearly demonstrates that environmental stresses, including iron limitation and extremes of pH, play an important role in modulating the physiology and virulence of L. pneumophila, inducing the expression of distinct phenotypes differing in their ability to persist in nature and cause infection.

10

Ricketts, Katherine. "The influence of environmental factors on sporadic cases of Legionnaires disease in England and Wales." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.549779.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Книги з теми "Legionnaires' disease":

1

Zonderman, Jon. Legionnaires' disease. Philadelphia: Chelsea House Publishers, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

executive, Health and safety. Legionnaires' disease. London: H.M.S.O., 1987.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Brundrett, G. W. Engineering aspects of legionnaires disease. Chester: Electricity Council Research Centre, 1986.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Rosa, Frank. Legionnaires' disease: Prevention and control. Troy, Mich: Business News Pub., 1993.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Great Britain. Expert Advisory Committee on Biocides. Report of the Expert Advisory Committee on Biocides. London: H.M.S.O., 1989.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Uzel, Atac. Legionella pneumophila: From environment to disease. Hauppauge, N.Y: Nova Science Pub., 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Freije, Matthew R. Legionellae control in health care facilities: A guide for minimizing risk. Edited by Barbaree James M. Indianapolis, IN: HC Information Resources, 1996.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

1943-, Katz Sheila Moriber, ed. Legionellosis. Boca Raton, Fla: CRC Press, 1985.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Atac, Uzel, and Hames-Kocabas E. Esin, eds. Legionella pneumophila: From environment to disease. Hauppauge, N.Y: Nova Science Pub., 2009.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Baxter, David. Legionnaires disease: A comprehensive description & contemporary bibliography. Manchester: University of Manchester, 1985.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "Legionnaires' disease":

1

Cianciotto, Nicholas P., Hubert Hilbi, and Carmen Buchrieser. "Legionnaires’ Disease." In The Prokaryotes, 147–217. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-30144-5_94.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Jia, Cuiyu, Dawei Zhao, and Jianan Yu. "Legionnaires’ Disease." In Radiology of Infectious Diseases: Volume 2, 121–30. Dordrecht: Springer Netherlands, 2015. http://dx.doi.org/10.1007/978-94-017-9876-1_12.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Roig, J., M. Sabria, and X. Castella. "Legionnaires’ Disease." In Infectious Diseases in Critical Care, 404–12. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-34406-3_37.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Kreutner, A. Karen. "Legionnaires’ Disease." In Principles of Medical Therapy in Pregnancy, 480–81. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2415-7_64.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Lucas, Claressa E., and Barry S. Fields. "Legionellaeand Legionnaires' Disease." In Manual of Environmental Microbiology, 3.2.9–1–3.2.9–13. Washington, DC, USA: ASM Press, 2015. http://dx.doi.org/10.1128/9781555818821.ch3.2.9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Roig, Jorge, and Jordi Rello. "Treatment of Legionnaires' Disease." In Legionella, 8–14. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555815660.ch02.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Brown, Andrew S., Ian R. van Driel, and Elizabeth L. Hartland. "Mouse Models of Legionnaires’ Disease." In Current Topics in Microbiology and Immunology, 271–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/82_2013_349.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Berrington, William R., and Thomas R. Hawn. "Human Susceptibility to Legionnaires’ Disease." In Methods in Molecular Biology, 541–51. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-161-5_33.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Brune, Michelle. "Legionnaires' Disease and Water Systems." In Architectural Factors for Infection and Disease Control, 65–77. New York: Routledge, 2022. http://dx.doi.org/10.4324/9781003214502-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Joseph, Carol. "Surveillance of Legionnaires' Disease in Europe." In Legionella, 311–17. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555817985.ch62.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Legionnaires' disease":

1

Muscedere, D., S. Sahni, Y. Malyshev, G. K. Upadhya, and R. Cofsky. "Making It Mental - Neurological Manifestations of Legionnaires’ Disease." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3691.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Hanna, S., I. Milojevic, and H. Patel. "Cerebellar Symptoms: An Uncommon Presentation of Legionnaires' Disease." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4500.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Cysneiros, Ana, Francisca Lopes, Joao Carvalho, Patricia Dionisio, Christine Costa, Bruno Von Amann, Ana Dias, et al. "Legionella score performance under an outbreak of Legionnaires' disease." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2576.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Saradna, A., R. Kunadharaju, B. Bahl, M. Ahmad, and M. Saeed. "Legionnaires' Disease Associated Secondary Hemophagocytic Lymphohistiocytosis and Erythema Multiforme." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3970.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Branco, Joana, Carlos Macedo, Nelson Marçal, Ana Alves, Catarina Pissarra, and Paula Rosa. "Pneumology outpatient clinic's role during an outbreak of Legionnaires' disease." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2582.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Mengiste, H. A., M. Jindal, Y. Gebrekidan, and A. Mehari. "A Case of Legionnaires' Disease Associated with Massive Gastrointestinal Bleeding." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6896.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Kumar, D., D. Kumar, Z. Khan, and M. Bachan. "A Rare Case of Rhabdomyolysis and Renal Failure Secondary to Legionnaires Disease." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3907.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Saad eldin, M., M. Alhamaydeh, U. Sana Ullah, and M. Imtiaz. "Severe Legionnaires' Disease with Multi-Systemorgan Failure Responding to Triple Antibiotic Therapy." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6904.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Brodhun, B., K. Prahm, C. Lück, W. Haas, and U. Buchholz. "Reiseassoziierte Fälle von Legionärskrankheit – Teilnahme Deutschlands am European Legionnaires' Disease Surveillance Network (ELDSNet)." In Der Öffentliche Gesundheitsdienst: Mitten in der Gesellschaft. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1679258.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Jahn, HJ, B. Brodhun, W. Haas, and U. Buchholz. "Legionnaires' Disease in Germany: trends and seasonal variations by exposure category; 2001 – 2016." In Gemeinsam forschen – gemeinsam handeln. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1605852.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Legionnaires' disease":

1

Tyndall, R. L., S. W. Christensen, and J. A. Solomon. Legionnaires' disease bacteria in power plant cooling systems: Phase 2. Office of Scientific and Technical Information (OSTI), April 1985. http://dx.doi.org/10.2172/5732566.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Health hazard evaluation report: evaluation of Legionnaires' disease risk and other health hazards at an offset printing company. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, April 2016. http://dx.doi.org/10.26616/nioshhhe201500653252.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Health hazard evaluation report: HETA-2011-0109-3162, Legionnaires' disease at an automobile and scrap metal shredding facility, New York. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, August 2012. http://dx.doi.org/10.26616/nioshheta201101093162.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.